It's possible. Or they could get bought out by big pharma and/or partner with them, so that they could fund trials. That kind of thing happens all the time - that might be the more likely scenario if they actually have the goods. We don't really know, but I still like this where it's priced at now based on potential. Plenty of biopharma is in the tens of millions, or even hundreds of millions, in MC, with no FDA approved product. Yes, they are in Phase II/III but still - people bet and take those risks even with high caps.
News 
Market Data 
Discover 
